NeuroMetrix, Inc. (NURO) Social Stream
NeuroMetrix Inc (NURO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NURO.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued December 24, 2020
Over the past 14 months, NURO's average upside potential has been 1,723.9%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NURO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The number of analysts covering the stock of NURO is greater than practically none of all US stocks.
- The variance in analysts' estimates of NURO is less than nearly 100% of all US stocks.
- NURO has a greater upside potential (average analyst target price relative to current price) than 97.04% of Medical Equipment stocks.
- The average analyst price target of NURO is greater than 86.7% of stocks in the small market cap category.
Is NURO a Buy, Hold or Sell? See the POWR Ratings now!